Cardiac Catheter Labs Intravenous Drug Therapy Guide

Size: px
Start display at page:

Download "Cardiac Catheter Labs Intravenous Drug Therapy Guide"

Transcription

1 Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab Nurse) Lou Beaumont ( Cardiology Pharmacist) Directorate & Speciality CAS Cardiology Date of submission Jan 2015 Date on which guideline must be reviewed Jan 2020 Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Patients undergoing procedures in the cardiac catheter labs - City Campus Version 1 Abstract Key Words Statement of the evidence base of the guideline has the guideline been peer reviewed by colleagues? IV Medication Guide Cath Lab IV drugs cath labs expert committee reports or opinions and / or clinical experiences of respected authorities Evidence base: (1-6) 1 NICE Guidance, Royal College Guideline, SIGN (please state which source). 2a 2b 3a 3b meta analysis of randomised controlled trials at least one randomised controlled trial at least one well-designed controlled study without randomisation at least one other type of well-designed quasi-experimental study 4 well designed non-experimental descriptive studies (ie comparative / correlation and case studies) 5 expert committee reports or opinions and / or clinical experiences of respected authorities 6 recommended best practise based on the clinical experience of the guideline developer Consultation Process Target audience MMC, Cardiology Pharmacy, Head of Service, Lead consultant cath labs, Cardiology Governance. Cardiac Cath Lab Nurses. This guideline has been registered with the trust. However, clinical guidelines are guidelines only. The interpretation and application of clinical guidelines will remain the responsibility of the individual clinician. If in doubt contact a senior colleague or expert. Caution is advised when using guidelines after the review date.

2 Method of by Abciximab (ReoPro ) Dr solution 10mg in 5mL. Pre filter into syringe using a 0.22 micron filter. Inject over 1 minute. G, S Pre filter solution using 0.22micron filter when infusion prepared. Infused usually at a rate of 7.5 micrograms/kg/hour. (up to maximum of 600 micrograms/hour.) The infusion is prepared in a 50mL syringe. A syringe pump or volumetric pump should be used to control the infusion rate See prescription chart in the appendix.

3 Method of by Adrenaline (Epinephrine) Dr unless local agreement solution 1 in 10,000 (1mg in 10mL) in prefilled syringe (and 1mL and 10mL ampoules) Amiodarone Dr solution 150mg in 3mL. Prefilled syringe 300mg in 10mL for cardiopulmonary resuscitation CPR For cardiac arrest: Inject rapidly. Administer via a central line or into a large peripheral vein. If injection administered via a peripheral vein it should be followed by a 20mL flush of S. Resuscitation: preferably use prefilled syringe and give as fast as possible (followed by flush). In extreme clinical emergencies: inject over a minimum of 3 with close ECG monitoring. (if pre-filled syringe unavailable the dose may be drawn from the ampoule(s) and diluted with 10-20mL G). G ONLY Administered into central vein using a volumetric pump. Loading dose: add required dose to 250mL G and give over 30 initially via volumetric pump. Alternatively administer loading dose in 25mL G over 30 using a syringe pump. Maintenance dose: add required dose to 500mL G and give over 24 hours via volumetric pump. Concentration must not be less than 0.6mg per ml. Alternatively administer maintenance dose in 48mL G over 24 hours using a syringe pump. Amiodarone should only be diluted with Glucose 5%. Do not mix with Sodium Chloride 0.9%. Flush with Glucose 5% only. Intravenous Amiodarone should be administered via a central venous catheter. Amiodarone given peripherally may result in serious tissue damage. In exceptional situations when placement of a central line is not possible, is high risk or will delay vital treatment, a peripheral line with good blood flow (such as antecubital fossa) may be used via a large bore cannula. Under no circumstances administer more than 2mg per ml by the peripheral route.

4 Method of by Aspirin UNLICENSED Add 5mL WFI to each 500mg vial Inject over 3-5 G,S Add required dose to mL bag of infusion fluid and infuse over 20. Atenolol Dr solution 5mg in 10mL May be further diluted to a convenient volume and injected at a rate of 1mg per minute G, S, GS Withdraw dose required and further dilute in mL bag of infusion fluid and infuse over 20. Doctor should be in attendance for infusion. ECG monitoring required. Monitor blood pressure and heart rate. Atropine Dr solution 600 micrograms in 1mL Inject over 3-5 G, S Preferably administer via a large peripheral vein (or central venous catheter) to avoid potential venous irritation as the preparation has a low ph Chlorphenamine (Chlorpheniramine) solution 10mg in 1mL Inject over at least 1 minute. G, S

5 Method of by Cyclizine solution 50mg in 1mL. Dilute to 10mL with WFI, G or S, before injection. Inject over 3-5 G, S Diazepam emulsion (Diazemuls) Dobutamine Dr solution 10mg in 2mL ampoule Further dilute with 8mL S to give 1mg/mL solution 250mg in 20mL ampoules. Further dilute for infusion Inject at a maximum rate of 1mL per minute into a large vein G ONLY For continuous intravenous infusion: add 2-8mL to 100mL G to give concentration of micrograms in 1mL. Maximum concentration 200mg in 500mL Volumetric pump required. G, S Further dilute for infusion with S or G. Suggested dilution: withdraw 40mL from a 500mL bag then add 2 ampoules (500mg) to the bag. This gives a 1mg per ml solution. In fluid restricted patients: refer to Critical Care guidelines. Rate of varies according to indication. Administer using a volumetric pump (or syringe pump if fluid restricted). Note: contraindicated in patients allergic to egg or soyabean. Some adsorption to plastic. Should be used within 6 hours. Reversal agent of sedative effects of Diazepam solution is FLUMAZENIL. Please see flumazenil for methods. Preferably administer via a central venous catheter or large peripheral vein to avoid potential venous irritation as the preparation has a low ph. Solution may turn slightly pink in prepared solutions, but no significant loss of potency is associated with this change. ECG monitoring required. SEE APPENDIX FOR CENTRAL INFUSION GUIDE

6 Method of by Dopamine solution 200mg in 5mL, 800mg in 5mL ampoules. Further dilute for infusion G, S Further dilute for infusion with S or G. Suggested dilutions: Peripheral : withdraw 20mL infusion fluid from a 500mL bag, add 800mg dopamine to give a 1.6mg per ml solution. Central vein : withdraw 40mL from a 500mL bag, then add 1600mg dopamine to give a 3.2mg per ml solution. restricted: refer to local protocols. Administer using a volumetric pump or syringe pump. Rate according to indication. Preferably administer via a central venous catheter or large peripheral vein to avoid potential venous irritation as the preparation has a low ph. Do not use concentration greater than 2mg per ml for peripheral. ECG monitoring required. SEE APPENDIX FOR CENTRAL AND PERIPHERAL INFUSION GUIDE. Eptifibatide solution 20mg in 10mL vial solution 75mg in 100mL vial Inject required dose over 1-2 S flush See prescription chart in the appendix. Infuse at a rate of 2micrograms/kg/minute using a volumetric pump

7 Method of by Flecainide Dr solution 150mg in 15mL ampoule Flucloxacillin This is a PENICILLINcheck allergy status of patient before Add 10mL WFI to 250mg and 500mg vial. Add 20mL WFI to 1g vial. Flumazenil Dr solution 500 micrograms in 5mL ampoule Over at least For doses up to 1g: Inject over 3-4 Inject required dose over 15 seconds. Further doses may be given at 60 second intervals if required. G (G flush) S, G (S preferred) May be diluted in 20mL to 500mL of G and given as an infusion using volumetric pump. Rate of infusion depends on indication. For doses above 1g: add the required dose to 100mL infusion fluid and infuse over G, S Dilute to a convenient volume with S or G and infuse via a syringe pump (Usual rate micrograms per hour). ECG monitoring required for bolus dose Preferably administer via a large peripheral vein (or central venous catheter) Flumazenil is the reversal agent for Diazemuls and should be available when these drugs are used.

8 using a side arm of a giving set or into indwelling cannula without further dilution Furosemide Gentamicin up to 50mg More than 50mg For once daily dosing For tds dosing solution 20mg in 2mL, 50mg in 5mL and 250mg in 25mL ampoules. solution 80mg in 2mL and 20mg in 2mL vials Required dose may be further diluted with S. Inject at a rate not exceeding 4mg per minute, i.e. give 20mg over 5. Inject slowly over 3-5 ). Can be with 10-20mL S or G to aid slow S ONLY Method of by container (Doctor does not need to be in attendance unless stated. Nurse can administer by infusion if instruction in this column) Further dilute in 50mL to 250mL of S. Infuse using a syringe pump or volumetric pump. Do not exceed a rate of 4mg per minute. S, G Add required dose to 100mL of infusion fluid and infuse over 60 For infusion dilute with mL S or G and administer over Additional Information NOTE: Levels should be monitored. See antibiotic intranet site for further information.

9 using a side arm of a giving set or into indwelling cannula without further dilution Glucose 50% Dr solution Heparin solution 5000units in 5mL solution 10,000units in 10mL and 20,000units in 20mL ampoules Small volume only. Inject over at least 5 mins. When used for the emergency treatment of hypoglycaemia may be administered slowly into a large peripheral vein. Inject over 3-5 as a loading dose prior to infusion Method of by container (Doctor does not need to be in attendance unless stated. Nurse can administer by infusion if instruction in this column) Central line preferred. For short infusions (e.g. 30 ) with insulin to treat hyperkalaemia, peripheral vein has been used. Additional Information Glucose 20% is less irritant and can be given via a peripheral vein for several hours. G, S See heparin intravenous infusion protocol for further information Infuse using a syringe pump at a rate according to APTT ratio. The concentration used for infusion must always be 1000units per ml

10 Compatibl e Method of by Heparin flushes Flush solution units/5ml G, S For use in the cardiac catheter lab as an intra-arterial flush by the operator. Also for the flushing of Catheters and wires pre- insertion into arterial sheath. Further dilute 5000 units of Heparin in 500mL Normal saline 0.9%. Protamine is the reversal agent for Heparin and should be readily available when this drug is being used. Please see Protamine for methods. Hydrocortisone sodium succinate (Solu- Cortef ) Isoprenaline UNLICENSED Add 2mL WFI to 100mg vial Inject over 1-10 G, S Further dilute for infusion to mL. The final concentration should be no greater than 1mg per 1ml. Infuse over using a volumetric pump. Please see appendix for information on.

11 Method of by Isosorbide Dinitrate solution 1mg/mL (0.1%)(various sizes). Further dilute for infusion G, S Dilute to 1mg in 2mL in syringe pump.(ie dilute with equal volume) Variable rate of infusion according to blood pressure and patient response. See guideline for use including monitoring requirements and Y-site incompatibilities. DO NOT add to PVC containers. Metoclopramide solution. 0.5mg per ml (50mL bottle)(0.05%) Preferred product as no required. solution 10mg in 2mL (Also 20mL Maxolon 'High dose' ampoules). Inject 10mg in 2mL preparation over 1-2 Infuse using a syringe pump (no needed). G, S, GS, H Dilute the high dose Maxolon (up to 2mg/kg) with at least 50mL infusion fluid. Infuse over at least 15. May be given by continuous infusion

12 Method of by Midazolam Dr solution 5mg in 5mL ampoule (conscious sedation), 10mg in 2mL ampoule (palliative care usually given by subcutaneous injection or infusion) Dose/rate according to indication. G, S, GS Infuse continuously using syringe pump. Standard concentration for infusion 1mg in 1mL Caution-Risk of overdose when administering for conscious sedation. Preferably administer via a large peripheral vein (or central venous catheter) to avoid potential venous irritation as the preparation has a low ph. Reversal agent of sedative effects of Midazolam solution is Flumazenil. Please see Flumazenil for methods. Morphine Sulphate Dr unless local agreement solution 10mg in 1mL. Further dilute with 9mL S to give 1mg/mL Over 5 G, S, GS, H May be infused continuously using syringe pump with adequate monitoring respiratory rate. Patient controlled analgesia prepared as for infusion. Reversal agent of opioid induced respiratory depression is Naloxone. Please see Naloxone for methods.

13 Method of by Naloxone Ondansetron Protamine Sulphate Dr solution 400micrograms in 1mL ampoule solution 4mg in 2mL and 8mg in 4mL ampoules solution 50mg in 5mL ampoule Dose may be diluted to a convenient volume with WFI, S or G and injected over 30 seconds. This may be repeated if necessary. Inject over 3-5 Inject over 10 G, S For reversal of opiate induced respiratory depression: Add 2mg (5 ampoules of naloxone 400micrograms in 1mL) to 500ml of infusion fluid. For emergency treatment of opioid overdose: Dilute 4mg in 20mL or 10mg in 50mL and infuse via a syringe pump (unlicensed concentration) G, S,H Dilute in mL of infusion fluid and infuse over 15. For continuous infusion dilute as above and infuse at a rate of 1mg per hour using a volumetric pump. In patients age 65 years or older, all intravenous doses for prevention of Chemotherapy Induced Nausea and Vomiting should be diluted in ml S or other compatible fluid and infused over at least 15 Maximum of 50mg given in one dose.

14 Method of by Teicoplanin Tirofiban (Aggrastat ) Solution for infusion (250mL bag) Add diluent provided (WFI) to 200mg and 400mg vial. Reconstitute each drug vial with the entire vial of WFI. Slowly inject the WFI down the vial wall, swirl gently or roll to ensure the powder fully dissolves. If a froth forms, leave for 15 to settle. Ready prepared solution for infusion 12.5mg in 250mL (50micrograms per ml). Inject over 3-5. G,S,GS, H May be further diluted and infused over 30. G, S Loading infusion rate followed by maintenance infusion rate according to body weight. Maximum duration of treatment should not exceed 108 hours. See prescription chart in the appendix.

15 Method of by Vancomycin Add 10mL WFI to each 500mg vial. Add 20mL WFI to each 1g vial. Further dilute for infusion. Verapamil Dr solution 5mg in 2mL Inject 5-10mg over 2-3. Observe continuously and monitor ECG and blood pressure. G, S Dilute 1g in 250mL infusion fluid. Maximum concentration is 5mg per ml. (10mg per ml in fluid restriction but increased risk of infusion related effects). Infuse at a rate not exceeding 10mg per minute using a volumetric pump (i.e. 1g over at least 100 ). G, S NOTE: Levels should be monitored. See antibiotic intranet site for further information. Preferably administer via a large peripheral vein (or central venous catheter) to avoid potential venous irritation as the preparation has a low ph.

Administration and Supply of Emergency Medicines

Administration and Supply of Emergency Medicines APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule

More information

Common Infusions for Neonatal Use

Common Infusions for Neonatal Use Common Infusions for Neonatal Use Document Title and Reference : Common Infusions for Neonatal Use Main Author (s) Dr N B Soni Ratified by: LSC CEG Date Ratified: May 2016 Review Date: May 2018 Version:

More information

Adrenaline 1mg in 10mL (1:10,000) Pre-filled syringe 3 Amiodarone 300mg/10mL Pre-filled syringe 5

Adrenaline 1mg in 10mL (1:10,000) Pre-filled syringe 3 Amiodarone 300mg/10mL Pre-filled syringe 5 Quick Reference Guide for: Cardiac Arrest Medicines Box (BLUE) Please Note: Any medicines given must form part of an Airway, Breathing, Circulation, Disability and Exposure (ABCDE) Assessment (9)999 must

More information

Algorithms for Symptom Management. In End of Life Care

Algorithms for Symptom Management. In End of Life Care Algorithms for Symptom Management In End of Life Care The Use of Drugs Beyond Licence (off label) -The Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK regulates the activity of the

More information

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe) Drug Max dose approved for IVP Dilution Rate Monitoring Parameters Acetazolamide 500 mg Reconstitute with at least 5ml sterile water (max concentration should not exceed 100mg/ml) 100-500 mg/min Hypotension

More information

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES

NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES WOMEN AND NEWBORN HEALTH SERVICE King Edward Memorial Hospital NEWBORN EMERGENCY TRANSPORT SERVICE MEDICAL GUIDELINES Transport Medication List Title of policy: Transport Medication List Date Revised:

More information

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use

Guideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document

More information

Southern Trust Home IV Service. Guidelines for the administration of IV antibiotics

Southern Trust Home IV Service. Guidelines for the administration of IV antibiotics Southern Trust Home IV Service Guidelines for the administration of IV antibiotics Title: Author: CLINICAL GUIDELINES ID TAG Antibiotic guidelines - Southern Trust Home IV service guidelines for the administration

More information

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet

Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Children & Young People s Directorate Paediatric-Neonatal Guidelines Checklist & Version Control Sheet 1 Name of Guideline / Policy/ Procedure MANAGEMENT OF ACUTE PAEDIATRIC ASTHMA Purpose of Procedure/

More information

MORPHINE ADMINISTRATION

MORPHINE ADMINISTRATION Introduction Individualised Administration Drug of Choice Route of Administration & Doses Monitoring of Neonates & high risk patients Team Management Responsibility Morphine Protocol Flow Chart Introduction

More information

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain

PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Index No: MMG43 PAEDIATRIC DOSAGE GUIDELINES For management of post-operative acute pain Version: 3.1 (Includes anti-emetics and naloxone) Date ratified: July 2013 Ratified by: (Name of Committee) Name

More information

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS

PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS PHARMACY SERVICE ARRANGEMENTS FOR THE SUPPLY OF PALLIATIVE CARE SYRINGES AND MEDICINES FOR COMMUNITY PATIENTS The benefits of prefilled syringes for palliative care from the hospital pharmacy service In

More information

ADENOSINE. ADRENALINE (Epinephrine)

ADENOSINE. ADRENALINE (Epinephrine) ADENOSINE Notes Arrhythmias I.V. Initial dose 150 micrograms/kg stat Increase dose if required by 50 micrograms/kg to a maximum of 300 micrograms/kg (or 500 micrograms/kg if over 28 days old) ADMINISTRATION

More information

Resuscitation Fluids

Resuscitation Fluids Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be

More information

Nab-Paclitaxel (Abraxane) and Gemcitabine For Pancreatic Adenocarcinoma Cumbria, Northumberland, Tyne & Wear Area Team

Nab-Paclitaxel (Abraxane) and Gemcitabine For Pancreatic Adenocarcinoma Cumbria, Northumberland, Tyne & Wear Area Team DRUG ADMINISTRATION SCHEDULE Day Drug Dose Route Diluent & Rate 1 8 15 Sodium Chloride 0.9% 100ml Infusion Fast Running Dexamethasone 8mg Oral Ondansetron 8mg Oral/ IV Chlorphenamine 10mg Intravenous Slow

More information

Controlled Document Number: Version Number: 1. Controlled Document Sponsor: Controlled Document Lead (Author): On: July Review Date: July 2020

Controlled Document Number: Version Number: 1. Controlled Document Sponsor: Controlled Document Lead (Author): On: July Review Date: July 2020 Guidelines for the Use of Naloxone in Palliative Care in Adult Patients CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: Controlled Document Number: Version Number: 1 Controlled Document Sponsor: Controlled

More information

2015 Edition. Trust Medicines Formulary

2015 Edition. Trust Medicines Formulary 2015 Edition Trust Medicines Formulary Introduction Trust Medicines Formulary This formulary summarises all medicines used within the Trust, the Trust defines medicines as any substance, controlled or

More information

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a)

Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a) Acute painful crisis in patients with sickle cell disease: Clinical Guidelines (HN-506a) Introduction The majority of acute painful crises in patients with sickle cell disease will be managed independently

More information

Critical Care Standard Infusion Concentrations

Critical Care Standard Infusion Concentrations Acetylcisteine (NAC) Actrapid - Human Insulin Addiphos 20mmol Addiphos 40mmol Adrenaline (Epinephrine) vs peripheral 10 g in 50mL 200mg per ml 50 units in 50mL 1 unit per ml sodium chloride 20 mmol in

More information

Trust Guideline for the Management of Patient Controlled Analgesia (PCA) in Adults

Trust Guideline for the Management of Patient Controlled Analgesia (PCA) in Adults Patient Controlled Analgesia (PCA) in Adults A clinical guideline recommended for use For Use in: In all Clinical Areas By: Anaesthetists, Ward Nurses, Recovery Staff Acute Pain Service Staff For: Adult

More information

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title

More information

** Medication exercises ** NICU Phase II

** Medication exercises ** NICU Phase II ** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Post-op, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She

More information

STATUTORY INSTRUMENTS. S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS 2014

STATUTORY INSTRUMENTS. S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS 2014 STATUTORY INSTRUMENTS. S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL OF SUPPLY) (AMENDMENT) REGULATIONS 2014 2 [300] S.I. No. 300 of 2014 MEDICINAL PRODUCTS (PRESCRIPTION AND CONTROL

More information

Zzbeacon,Zayna [MR ]

Zzbeacon,Zayna [MR ] AALL1131 INTERIM MAINTENANCE, HR-ALL, ARM B, HD MTX Properties Cycle 1 9/27/2012 through 11/28/2012 (63 days), Planned Day 1, Cycle 1 Planned for 9/27/2012 Release CBC and differential Release Release

More information

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the

More information

GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE

GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE GUIDELINES FOR ADMINISTRATION OF INTRAVENOUS IRON IN ADULTS WITH CHRONIC KIDNEY DISEASE Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target audience, state if

More information

PHARMACOLOGY AND PHARMACOKINETICS

PHARMACOLOGY AND PHARMACOKINETICS DRUG GUIDELINE Insulin, human neutral (Actrapid ) Intravenous Infusion for SCOPE (Area): FOR USE IN: Critical Care Unit, Emergency Department and Operating Suite EXCLUSIONS: Paediatrics (seek Paediatrician

More information

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH

UTMB DEPARTMENT OF PHARMACY POLICY AND PROCEDURES Section Medication Use ADMINISTRATION OF MEDICATION BY IV PUSH Page 1 of 8 ADMINISTRATION OF MEDICATION BY IV PUSH AUDIENCE POLICY This document is directed to Registered Nurses (RNs), Licensed Vocational Nurses (LVN s), and physicians. The following delineates the

More information

RECONSTITUTION, DOSING AND ADMINISTRATION

RECONSTITUTION, DOSING AND ADMINISTRATION Prescribing Information can be found within this document CORRECT RECONSTITUTION FOR SC AND IV ADMINISTRATION VELCADE (bortezomib) 3.5 mg powder for solution for injection is available for intravenous

More information

Injection Dosage Calculations

Injection Dosage Calculations INJECTIONS: QUIZ 3 Injection Dosage Calculations 1. A child is ordered 9 mg of gentamicin by IM. Stock ampoules contain 20 mg in 2 ml. What volume is needed for the injection? a. 0.9 ml b. 0.5 ml c. 2.2

More information

concentrate intravenous solution and other strong potassium solutions

concentrate intravenous solution and other strong potassium solutions Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous

More information

IV drug preparation guidelines. Prepared by pharmacist Eman Elayeh

IV drug preparation guidelines. Prepared by pharmacist Eman Elayeh IV drug preparation guidelines Prepared by pharmacist Eman Elayeh Injectable drugs guide The monographs in this book detail appropriate methods of administration for medicines that can be given via the

More information

CLINICAL POLICY FOR THE USE OF INTRANASAL DIAMORPHINE FOR ANALGESIA IN CHILDREN ATTENDING THE PAEDIATRIC EMERGENCY DEPARTMENT, SASH

CLINICAL POLICY FOR THE USE OF INTRANASAL DIAMORPHINE FOR ANALGESIA IN CHILDREN ATTENDING THE PAEDIATRIC EMERGENCY DEPARTMENT, SASH CLINICAL POLICY FOR THE USE OF INTRANASAL DIAMORPHINE FOR ANALGESIA IN CHILDREN ATTENDING THE PAEDIATRIC EMERGENCY DEPARTMENT, SASH Background Adequate analgesia is a vital aspect of early management of

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS EPTIFIBATIDE (INTEGRILIN) PROTOCOL

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS EPTIFIBATIDE (INTEGRILIN) PROTOCOL NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE S EPTIFIBATIDE (INTEGRILIN) I. PURPOSE: A. Integrilin (Eptifibatide) is a specific and potent inhibitor of the platelet receptor glycoprotein

More information

Guideline for the use of Clonidine for Sedation in Adult Intensive Care

Guideline for the use of Clonidine for Sedation in Adult Intensive Care Guideline for the use of Clonidine for Sedation in Adult Intensive Care This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the

More information

Core procedures assessment form

Core procedures assessment form 1. Venepuncture guidance choose appropriate needle or cannula have appropriate vials to hand choose a suitable, palpable vein after applying tourniquet insert needle with bevel upwards and advance 2-3mm

More information

6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center

6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center RATE Abciximab (Reopro) Alteplase (tpa, Activase) All units 6S and 6W ONLY Platelet aggregation inhibitor Thrombolytic agent Bolus: 0.25 mg/kg IV over 5 min Infusion: 0.125 0.9 mg/kg (max 90 mg); 10% of

More information

Staff at the Nottingham Children s Hospital. Guidelines process.

Staff at the Nottingham Children s Hospital. Guidelines  process. Diabetes and Surgery Title of Guideline Contact Name and Job Title (author) Guideline for the management of children and young people with diabetes aged 18 or under requiring surgery Dr Priyha Santhanam,

More information

Statutory Instrument. S.I. No. 510 of Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2005

Statutory Instrument. S.I. No. 510 of Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2005 Statutory Instrument S.I. No. 510 of 2005 Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2005 PUBLISHED BY THE STATIONERY OFFICE, DUBLIN To be purchased directly from the

More information

Zzbeacon,Zayna [MR ]

Zzbeacon,Zayna [MR ] AALL1131-DS INDUCTION HR-ALL, DAYS 1-14 Properties Cycle 1 9/27/2012 through 10/10/2012 (14 days), Planned Day 1, Cycle 1 Planned for 9/27/2012 Release Labs CBC and differential Release Release Comprehensive

More information

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259

CONTROLLED DOCUMENT. Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) Controlled Document Number: CG259 Guidelines for the use of subcutaneous hydration in palliative care (hypodermoclysis) CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: Controlled Document Number: Version Number: 1 Controlled Document Sponsor:

More information

Medicines Included in Deteriorating Patients medicine Box (RED):

Medicines Included in Deteriorating Patients medicine Box (RED): Quick Reference Guide for: Deteriorating Patients Medicines Box (RED) Please Note: Any medicines given must form part of an Airway, Breathing, Circulation, Disability and Exposure (ABCDE) Assessment (9)999

More information

Syringe driver in Palliative Care

Syringe driver in Palliative Care Syringe driver in Palliative Care Introduction: Syringe drivers are portable, battery operated devices widely used in palliative care to deliver medication as a continuous subcutaneous infusion over 24

More information

GUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK

GUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK GUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK Contact Name and Job Title (author) Directorate & Speciality Jr Sr Vanessa Keill Diabetes, Infection, Renal and Cardiovascular Directorate (Renal

More information

PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING

PCA PRESCRIPTION is valid for a maximum of 4 days unless ceased earlier. Date: BINDING MARGIN - NO WRITING BINDING MARGIN - NO WRITING Attach ADR Sticker THESE INSTRUCTIONS EXPLAIN WHEN TO MAKE A CLINICAL REVIEW OR RAPID RESPONSE CALL, YOUR LOCAL ESCALATION PROTOCOL WILL EXPLAIN HOW TO MAKE A CALL PCA ALLERGIES & ADVERSE DRUG REACTIONS

More information

NOTICES DEPARTMENT OF HEALTH

NOTICES DEPARTMENT OF HEALTH NOTICES DEPARTMENT OF HEALTH Approved Drugs for ALS Ambulance Services [42 Pa.B. 4229] [Saturday, July 7, 2012] Under 28 Pa. Code 1005.11(b) (relating to drug use, control and security), the following

More information

Trust Protocol for the Administration of Intravenous Methylprednisolone for Thyroid Eye Disease A Protocol. The Clinical Investigation Unit (CIU)

Trust Protocol for the Administration of Intravenous Methylprednisolone for Thyroid Eye Disease A Protocol. The Clinical Investigation Unit (CIU) A Protocol For Use in: By: For: Division responsible for document: Key words: Name of document author: Job title of document author: Name and job title of document author s Line Manager: Supported by:

More information

CLINICAL GUIDELINES ID TAG

CLINICAL GUIDELINES ID TAG Title: Author: Speciality/ Division: Directorate: Date Uploaded: Review Date: September 2019 CG ID TAG CG0423 CLINICAL GUIDELINES ID TAG Clinical Guideline for Alteplase in intra-arterial thrombolysis

More information

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS

Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS Chapter 8 ADMINISTRATION OF BLOOD COMPONENTS PRACTICE POINTS Give the right blood product to the right patient at the right time. Failure to correctly check the patient or the pack can be fatal. At the

More information

Isle of Wight Syringe Driver Compatibility Guidelines

Isle of Wight Syringe Driver Compatibility Guidelines Isle of Wight Syringe Driver Compatibility Guidelines Produced by The Earl Mountbatten Hospice, Isle of Wight Written January 2015, revision due January 2018 This guideline is available as a paper pocketbook

More information

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES Adult Drug Reference Dopamine Drip Chart Pediatric Drug Reference Pediatric Drug Dosage Charts DRUG REFERENCES ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal

More information

Antiallergics and drugs used in anaphylaxis

Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis The H 1 -receptor antagonists are generally referred to as antihistamines. They inhibit the wheal, pruritus, sneezing

More information

SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY

SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY PS1006 SARASOTA MEMORIAL HOSPITAL DEPARTMENT POLICY TITLE: PHARMACEUTICALS FOR CRITICAL CARE AREAS, HEMODIALYSIS, PACU, EMERGENCY CARE CENTER, CARDIAC CARE AREAS, NEURO PROGRESSIVE CARE, AND THE MECKLER

More information

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.

Care of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure. Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients

More information

West Penn Allegheny Health System Forbes Regional Hospital

West Penn Allegheny Health System Forbes Regional Hospital Policy Name: Treatment of Anaphylactic Reaction In the Cath Lab Original Date: West Penn Allegheny Health System Forbes Regional Hospital Policy No. 16553 Page 1 of 6 Reviewed by : Mark Taylor, MD, Michael

More information

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments ADENOSINE Paroxysmal SVT 1 st Dose 6 mg rapid IV 2 nd & 3 rd Doses 12 mg rapid IV push Follow each dose with rapid bolus of 20 ml NS May cause transient heart block or asystole. Side effects include chest

More information

SPAGG. Coversheet for Specialist Palliative Audit and Guideline Group Agreed Documentation

SPAGG. Coversheet for Specialist Palliative Audit and Guideline Group Agreed Documentation SPAGG Coversheet for Specialist Palliative Audit and Guideline Group Agreed Documentation This sheet is to accompany all documentation agreed by SPAGG. This will assist maintenance of the guidelines as

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide For needle and needle-free systems This guide provides detailed instructions on the reconstitution, dilution, and storage of VELETRI. It is intended to be used after your

More information

post-operative, nausea, vomiting, antiemetics

post-operative, nausea, vomiting, antiemetics Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the prevention and treatment of Postoperative

More information

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE

ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ADULT (>16) ACUTE SICKLE PAIN GUIDELINE ID 2013 065 Author s Name Dr Anna Wood Author s Job Title Consultant Haematologist Division Consultant Haematologist Department Haematology Version number 3 Ratifying

More information

INTRAVENOUS HYDRALAZINE POLICY

INTRAVENOUS HYDRALAZINE POLICY PURPOSE INTRAVENOUS HYDRALAZINE POLICY The purpose of this policy is to: provide safe and effective care for women establish a local approach to care that is evidence based and consistent inform good decision

More information

IV Referral Standards for OPAT Services

IV Referral Standards for OPAT Services pecialist harmacy ervice Medicines Use and afety IV Referral tandards for OAT ervices andra Wolper Associate Director Medicines Use and afety Division pecialist harmacy ervices pecialist harmacy ervice

More information

Antibiotic line locks for central venous catheters in adult patients on haemodialysis

Antibiotic line locks for central venous catheters in adult patients on haemodialysis Trust Clinical Guidelines Derby Hospitals NHS Foundation Trust Antibiotic line locks for central venous catheters in adult patients on haemodialysis Introduction Reference No: Microbial colonisation of

More information

A Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children

A Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children For Use in: By: For: Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager: Supported by: Assessed and approved by the:

More information

PHYSICIAN ORDER SET : Patient: DOB: Gender: Patient Phone #: Height: Weight:

PHYSICIAN ORDER SET : Patient: DOB: Gender: Patient Phone #: Height: Weight: . (Patient Sticker) CDH 208-203 Approved 2/18 - Page 1 of 5 Patient: DOB: Gender: Patient Phone #: Height: Weight: Diagnosis: ICD-10 Code: Treatment Start Date: Provider Facility Name: Ordering Provider:

More information

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines.

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines. STANDARDS All blood components are administered according to BOP DHB Policy and NZBS Guidelines. EQUIPMENT IV administration set with 260 micron filter either integrated blood filter; or add on blood filter

More information

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Guideline on the management of excessive coumarin anticoagulation in adults

More information

INFLIXIMAB RHEUMATOLOGY LOAD DOSE (SCHEDULE WEEKS 0, 2, 6)

INFLIXIMAB RHEUMATOLOGY LOAD DOSE (SCHEDULE WEEKS 0, 2, 6) . INFLIXIMAB RHEUMATOLOGY LOAD DOSE (SCHEDULE CDH 208-211 Approved 2/18 - Page 1 of 5 Patient: DOB: Gender: Patient Phone #: Height: Weight: Diagnosis: ICD-10 Code: Treatment Start Date: Provider Facility

More information

FOLFIRINOX (Irinotecan, Oxaliplatin & infusional Fluorouracil) Cumbria, Northumberland, Tyne & Wear Area Team

FOLFIRINOX (Irinotecan, Oxaliplatin & infusional Fluorouracil) Cumbria, Northumberland, Tyne & Wear Area Team DRUG ADMINISTRATION SCHEDULE Day Drug Dose Route Diluent & Rate Glucose 5% 250ml Infusion Fast Running for Line Flush Day 1 Ondansetron 8mg IV bolus Via dextrose drip Dexamethasone 8mg IV bolus Via dextrose

More information

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug

ALLERGIES/ SENSITIVITIES This section must be completed before prescribing/administering any drug COMMUNITY PRESCRIPTION CHART All entries should be in CAPITAL letters and in indelible black ink. If medications/ doses are stopped, cross through the relevant line clearly to avoid error. GP: PRESCRIBER

More information

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. DISPENSING OR SELLING NALOXONE Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug. UPDATED ON: April 21, 2017 Purpose The intent of this document is to provide

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 24 June 2009

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 24 June 2009 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 24 June 2009 PROPOFOL LIPURO 1% (10 mg/ml) emulsion for injection or for infusion B/5 glass ampoules of 20 ml (CIP

More information

CHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL

CHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL CHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL Item Changed Airway Management Procedure Oral Intubation Procedure Tube Confirmation and Monitoring Procedure C10 Chest Pain/ACS M2 Allergic Reaction/Anaphylaxis

More information

Diabetes Labour guideline (GL820)

Diabetes Labour guideline (GL820) Diabetes Labour guideline (GL820) Approval Approval Group Job Title, Chair of Committee Date Maternity & Childrens Services Mr Mark Selinger, Consultant 6 th June 2014 Clinical Governance Committee Obstetrician

More information

INPATIENT INTERVENTIONAL RADIOLOGY PLAN - Phase: Pre-Procedure Orders

INPATIENT INTERVENTIONAL RADIOLOGY PLAN - Phase: Pre-Procedure Orders - Phase: Pre-Procedure Orders DETAILS Patient Care Obtain Consent If one is not present on chart today. Vital Signs Per Policy Insert Peripheral Line T;N, Start IV on right side If left radial access is

More information

Nassau Regional Emergency Medical Services. Advanced Life Support Pediatric Protocol Manual

Nassau Regional Emergency Medical Services. Advanced Life Support Pediatric Protocol Manual Nassau Regional Emergency Medical Services Advanced Life Support Pediatric Protocol Manual 2014 PEDIATRIC ADVANCED LIFE SUPPORT PROTOCOLS TABLE OF CONTENTS Approved Effective Newborn Resuscitation P 1

More information

DR J HARTY / DR CM RITCHIE / DR M GIBBONS

DR J HARTY / DR CM RITCHIE / DR M GIBBONS CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Paracetamol Poisoning DR J HARTY / DR CM RITCHIE / DR M GIBBONS Medicine Acute Date Uploaded: 16 th September 2014 Review Date

More information

Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE

Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS UMHHC-HCS: 253.054 First Approved Date: 3/2010 Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating

More information

DRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy)

DRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy) DRUG GUIDELINE HYDRALAZINE (Intravenous severe hypertension SCOPE (Area): FOR USE IN: Labour Ward, HDU, Theatre and ED EXCLUSIONS: Paediatrics (seek Paediatrician advice) and other general wards. SCOPE

More information

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes

More information

CONTRAST ENHANCED IMAGING HOW TO GET STARTED: A Tale From A Facility Like Yours

CONTRAST ENHANCED IMAGING HOW TO GET STARTED: A Tale From A Facility Like Yours The presentation will begin in a few moments. CONTRAST ENHANCED IMAGING HOW TO GET STARTED: A Tale From A Facility Like Yours For technical support, call 800-679-3646 CONTRAST ENHANCED IMAGING HOW TO GET

More information

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague,

From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Dear NHS Colleague, Supporting document for NPSA Injectables Patient Safety Alert Attached is a document

More information

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol 1. Aim/Purpose of this Guideline 1.1. To Provide safe and efficient administration of Opioids in Recovery.

More information

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017 EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. Course Outline Introduction and Overview

More information

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text]

[Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] [Type text] Anticipatory Medication STAT dose and Syringe Driver Guidance [Type text] Patients with egfr greater than 30mL/min Patients with egfr less than 30mL/min Symptom Drug Dose Symptom Drug Dose

More information

Objectives: This presentation will help you to:

Objectives: This presentation will help you to: emergency Drugs Objectives: This presentation will help you to: Five rights for medication administration Recognize different cardiac arrhythmias and determine the common drugs used for each one List the

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide This guide provides detailed instruction on the reconstitution, dilution, and storage of Veletri (epoprostenol) for Injection. It is intended to be used after your healthcare

More information

Intravenous therapy and medication. ELCT Health Department Quality Assurance 2007

Intravenous therapy and medication. ELCT Health Department Quality Assurance 2007 Intravenous therapy and medication ELCT Health Department Quality Assurance 2007 Intravenous therapy and medication the procedure is absolutely sterile, everything should be handled remaining sterility

More information

ASEPTIC DISPENSING TECHNIQUES/DRUG- NUTRIENT INTERACTIONS

ASEPTIC DISPENSING TECHNIQUES/DRUG- NUTRIENT INTERACTIONS ASEPTIC DISPENSING TECHNIQUES/DRUG- NUTRIENT INTERACTIONS HARBANS KAUR DHILLON PRESIDENT OF PENSMA KUALA LUMPUR MALAYSIA PENSA 2007 University Malaya Medical Centre Kuala Lumpur ASEPTIC DISPENSING Ppn

More information

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job

More information

DOCUMENT CONTROL PAGE

DOCUMENT CONTROL PAGE DOCUMENT CONTROL PAGE Title Title: Version: 3 Reference Number: Supersedes Supersedes: All previous versions (2006) Description of Amendment(s): New hospital contact details applied. Originator or modifier

More information

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 1 2 EMT OPTIONAL SKILL Naloxone Intranasal Cell Phones and Pagers Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off. 3 4 5 6 Course Outline Introduction

More information

This guideline describes the care required for a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies.

This guideline describes the care required for a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies. Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guidelines for care of a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies.

More information

CICU STANDARD INTRAVENOUS INFUSIONS CHART

CICU STANDARD INTRAVENOUS INFUSIONS CHART IU STANDARD INTRAVENOUS INFUSIONS HART Full Title of uideline: Author (include email and role): Division & Speciality: Version: 2 Ratified by: Scope (Target audience, state if Trust wide): Review date

More information

Midazolam for seizures: Buccal administration

Midazolam for seizures: Buccal administration Midazolam for seizures: Buccal administration Rationale Buccal Midazolam is a convenient and efficient method used to treat prolonged seizures and status epilepticus in children. It can be used in hospital

More information

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.

For patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice. Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative

More information

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services VIOLENCE, AGGRESSION OR SEVERE BEHAVIOURAL DISTURBANCE Introduction During an acute episode or illness, some

More information

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline

APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Drug name APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Unit costs and weighted average unit costs for drug used in the treatment of focal and generalised epilepsies Prescription Cost

More information